Literature DB >> 25252827

Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Andrew P Ambrosy1, Mihai Gheorghiade, Ovidiu Chioncel, Robert J Mentz, Javed Butler.   

Abstract

Heart failure (HF) is a public health problem of global proportions afflicting more than 25 million patients worldwide. Despite stable or declining per capita hospitalization rates in the USA and several European countries, there are over one million hospitalizations for HF annually in the USA, with similar numbers in Europe, accounting for 6.5 million hospital days and the majority of the approximately $40 billion spent each year on HF-related care. Moreover, clinical trial data suggest that post-discharge survival and readmissions have largely remained unchanged. Thus, understanding geographic and ethnic variations in HF is essential to formulating public policy at the local, national, regional, and international levels and setting the agenda for basic, translational, and clinical research endeavors. This paper aims to describe regional and ethnic variations in patient characteristics, management, and outcomes in hospitalized HF.

Entities:  

Mesh:

Year:  2014        PMID: 25252827     DOI: 10.1007/s11897-014-0221-9

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  93 in total

Review 1.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

Authors:  Robb D Kociol; Peter S Pang; Mihai Gheorghiade; Gregg C Fonarow; Christopher M O'Connor; G Michael Felker
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

Review 2.  Heart failure burden and therapy.

Authors:  Faiez Zannad; Nelly Agrinier; François Alla
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

3.  The burden of heart failure in Africa.

Authors:  Gad Cotter; Beth Cotter-Davison; Okechukwu S Ogah
Journal:  Eur J Heart Fail       Date:  2013-05-05       Impact factor: 15.534

4.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?

Authors:  S Stewart; K MacIntyre; M M MacLeod; A E Bailey; S Capewell; J J McMurray
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

Review 5.  Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.

Authors:  Norman C Wang; Jonathan P Piccini; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

6.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

Authors:  Markku S Nieminen; Dirk Brutsaert; Kenneth Dickstein; Helmut Drexler; Ferenc Follath; Veli-Pekka Harjola; Matthias Hochadel; Michel Komajda; Johan Lassus; Jose Luis Lopez-Sendon; Piotr Ponikowski; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

7.  Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

Authors:  C W Yancy; M B Fowler; W S Colucci; E M Gilbert; M R Bristow; J N Cohn; M A Lukas; S T Young; M Packer
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

8.  Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

Authors:  James B Young; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; Clyde W Yancy; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

9.  Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors:  Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

10.  Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).

Authors:  Wendy A Gattis; Christopher M O'Connor; Vic Hasselblad; Kirkwood F Adams; Isaac Kobrin; Mihai Gheorghiade
Journal:  Am J Cardiol       Date:  2004-06-01       Impact factor: 2.778

View more
  17 in total

Review 1.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

2.  In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry.

Authors:  Ganapathi Sanjay; Panniyammakal Jeemon; Anubha Agarwal; Sunitha Viswanathan; Madhu Sreedharan; Govindan Vijayaraghavan; Charantharayil Gopalan Bahuleyan; R Biju; Tiny Nair; N Prathapkumar; G Krishnakumar; N Rajalekshmi; Krishnan Suresh; Lawrence P Park; Mark D Huffman; Sivadasanpillai Harikrishnan
Journal:  J Card Fail       Date:  2018-06-07       Impact factor: 5.712

Review 3.  Revisiting the physiological effects of exercise training on autonomic regulation and chemoreflex control in heart failure: does ejection fraction matter?

Authors:  David C Andrade; Alexis Arce-Alvarez; Camilo Toledo; Hugo S Díaz; Claudia Lucero; Rodrigo A Quintanilla; Harold D Schultz; Noah J Marcus; Markus Amann; Rodrigo Del Rio
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

Review 4.  Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.

Authors:  Muthiah Vaduganathan; Javed Butler; Lothar Roessig; Gregg C Fonarow; Stephen J Greene; Marco Metra; Gadi Cotter; Stuart Kupfer; Andrew Zalewski; Naoki Sato; Gerasimos Filippatos; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

5.  Autonomic regulation device therapy in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ahmed Bendary; Mohamed Bendary; Mohamed Salem
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

6.  Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy.

Authors:  Andrew P Ambrosy; Susanna R Stevens; Hussein R Al-Khalidi; Jean L Rouleau; Nadia Bouabdallaoui; Peter E Carson; Christopher Adlbrecht; John G F Cleland; Rafal Dabrowski; Krzysztof S Golba; Ileana L Pina; Carla A Sueta; Ambuj Roy; George Sopko; Robert O Bonow; Eric J Velazquez
Journal:  Eur J Heart Fail       Date:  2019-01-30       Impact factor: 15.534

Review 7.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

8.  International collaboration: promises and challenges.

Authors:  R Jay Widmer; Jocelyn M Widmer; Amir Lerman
Journal:  Rambam Maimonides Med J       Date:  2015-04-29

9.  Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure.

Authors:  Crystel M Gijsberts; Lina Benson; Ulf Dahlström; David Sim; Daniel P S Yeo; Hean Yee Ong; Fazlur Jaufeerally; Gerard K T Leong; Lieng H Ling; A Mark Richards; Dominique P V de Kleijn; Lars H Lund; Carolyn S P Lam
Journal:  Heart       Date:  2016-07-11       Impact factor: 5.994

10.  Heart failure impairs mood and memory in male rats and down-regulates the expression of numerous genes important for synaptic plasticity in related brain regions.

Authors:  Marise B Parent; Hildebrando Candido Ferreira-Neto; Ana Rafaela Kruemmel; Ferdinand Althammer; Atit A Patel; Sreinick Keo; Kathryn E Whitley; Daniel N Cox; Javier E Stern
Journal:  Behav Brain Res       Date:  2021-07-16       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.